Risks and limits of CRP Männer

CRP (C-reactive protein) is a non-specific inflammatory marker often measured in men for cardiovascular risk assessment. Elevated CRP levels indicate systemic inflammation, which can stem from infections, chronic diseases, smoking, or obesity. The evidence linking CRP to cardiovascular risk is human-strong, but CRP is not a standalone diagnostic tool. Its limits include lack of specificity: a high CRP alone does not confirm heart disease. CRP is also influenced by acute infections, injuries, or intense exercise. In men, moderately elevated CRP (e.g., 2–10 mg/L) may suggest increased risk, but clinical decisions should rely on a full profile (LDL, HDL, blood pressure, smoking status). Consumer tests like the MyBody-X nutrient test do not typically measure CRP; if they do, interpretation without medical context is problematic. Safety note: no direct harm from measurement, but misinterpretation can cause anxiety or false reassurance. Guidelines recommend CRP testing only in intermediate-risk individuals per Framingham score. Evidence: human-strong for association, but limits in clinical application.